Skip to content
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
Insights
About
Authors & Reviewers
Sign In
Subscribe
Sign in
Subscribe
Clinical Topics
View All
Addiction
ADHD
Alzheimer’s Disease
Anxiety
Bipolar Disorder
Depression
Movement Disorders
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia/Schizoaffective Disorders
Sleep
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Evolving Psychedelic Paradigm
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
JCP Podcast
Rounds in the General Hospital
View All
Glenn E. Matroos, MD, PhD
JCP
Original Research
Antipsychotic Changes Affecting Tardive Dyskinesia and Parkinsonism
March 29, 2017
Can switching antipsychotic type or changing the dose reduce the symptoms of parkinsonism and tardive dyskinesia? Review the drug effects with changes in high and low dopamine-2 affinity in...
Peter N. van Harten
,
Charlotte L. Mentzel
,
P. Roberto Bakker
, et al
JCP
Original Research
Incidence of Tardive Dyskinesia and Tardive Dystonia in African Caribbean Patients on Long-Term Antipsychotic Treatment: The Curaçao Extrapyramidal Syndromes Study V
December 15, 2006
Peter N. van Harten
,
Jim van Os
,
Glenn E. Matroos
, et al
JCP
Original Research
Cocaine as a Risk Factor for Neuroleptic-Induced Acute Dystonia
March 15, 1998
Peter N. van Harten
,
Glenn E. Matroos
,
Hans W. Hoek
, et al
